297 related articles for article (PubMed ID: 34094974)
1. Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy.
Xu C; Wang M; Guo W; Sun W; Liu Y
Front Oncol; 2021; 11():672490. PubMed ID: 34094974
[TBL] [Abstract][Full Text] [Related]
2. Targeting Signaling Pathway by Curcumin in Osteosarcoma.
Farnood PR; Pazhooh RD; Asemi Z; Yousefi B
Curr Mol Pharmacol; 2023; 16(1):71-82. PubMed ID: 35400349
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of Curcumin-Modified TiO
Zhang M; Zhang J; Chen J; Zeng Y; Zhu Z; Wan Y
Adv Healthc Mater; 2019 Dec; 8(23):e1901031. PubMed ID: 31664793
[TBL] [Abstract][Full Text] [Related]
4. Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.
Lu KH; Lu PW; Lu EW; Lin CW; Yang SF
Int J Biol Sci; 2023; 19(4):1241-1265. PubMed ID: 36923933
[TBL] [Abstract][Full Text] [Related]
5. The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art.
Zahedipour F; Bolourinezhad M; Teng Y; Sahebkar A
J Oncol; 2021; 2021():3006853. PubMed ID: 34671398
[TBL] [Abstract][Full Text] [Related]
6. Curcumin in human osteosarcoma: From analogs to carriers.
Lu KH; Lu PW; Lin CW; Yang SF
Drug Discov Today; 2023 Feb; 28(2):103437. PubMed ID: 36372327
[TBL] [Abstract][Full Text] [Related]
7. Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway.
Aziz MNM; Hussin Y; Che Rahim NF; Nordin N; Mohamad NE; Yeap SK; Yong CY; Masarudin MJ; Cheah YK; Abu N; Akhtar MN; Alitheen NB
Molecules; 2018 Jan; 23(1):. PubMed ID: 29303982
[TBL] [Abstract][Full Text] [Related]
8. A review and outlook in the treatment of osteosarcoma and other deep tumors with photodynamic therapy: from basic to deep.
Yu W; Zhu J; Wang Y; Wang J; Fang W; Xia K; Shao J; Wu M; Liu B; Liang C; Ye C; Tao H
Oncotarget; 2017 Jun; 8(24):39833-39848. PubMed ID: 28418855
[TBL] [Abstract][Full Text] [Related]
9. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
[TBL] [Abstract][Full Text] [Related]
10. Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy.
Yu W; Wang Y; Zhu J; Jin L; Liu B; Xia K; Wang J; Gao J; Liang C; Tao H
Biomaterials; 2019 Feb; 192():128-139. PubMed ID: 30448697
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
[TBL] [Abstract][Full Text] [Related]
13. The role of miR-21/RECK in the inhibition of osteosarcoma by curcumin.
Zhou L; Lu Y; Liu JS; Long SZ; Liu HL; Zhang J; Zhang T
Mol Cell Probes; 2020 Jun; 51():101534. PubMed ID: 32081769
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
Maiti P; Plemmons A; Dunbar GL
PLoS One; 2019; 14(12):e0225660. PubMed ID: 31841506
[TBL] [Abstract][Full Text] [Related]
15. Melatonin: an anti-tumor agent for osteosarcoma.
Fathizadeh H; Mirzaei H; Asemi Z
Cancer Cell Int; 2019; 19():319. PubMed ID: 31798348
[TBL] [Abstract][Full Text] [Related]
16. The Curcumin Analog CH-5 Exerts Anticancer Effects in Human Osteosarcoma Cells via Modulation of Transcription Factors p53/Sp1.
Lima FT; Seba V; Silva G; Torrezan GS; Polaquini CR; Pinhanelli VC; Baek SJ; Fachin AL; Regasini LO; Marins M
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966255
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits hypoxia-induced proliferation and invasion of MG-63 osteosarcoma cells via downregulating Notch1.
Wang Z; Zhang K; Zhu Y; Wang D; Shao Y; Zhang J
Mol Med Rep; 2017 Apr; 15(4):1747-1752. PubMed ID: 28138706
[TBL] [Abstract][Full Text] [Related]
18. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.
Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z
Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550
[TBL] [Abstract][Full Text] [Related]
19. Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition.
Kubista B; Schoefl T; Mayr L; van Schoonhoven S; Heffeter P; Windhager R; Keppler BK; Berger W
J Exp Clin Cancer Res; 2017 Apr; 36(1):52. PubMed ID: 28403890
[TBL] [Abstract][Full Text] [Related]
20. Design strategies and evolving role of biomaterial assisted treatment of osteosarcoma.
Quadros M; Momin M; Verma G
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111875. PubMed ID: 33579498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
